ESPANARO LTD
Company number 12836498 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: ESPANARO LTD
1. Financial Health Score: D (Poor)
Explanation: The company exhibits significant symptoms of financial distress, most notably negative shareholders’ funds (net liabilities) and high leverage. However, there are signs of recovery: a return to profitability in 2025 and positive working capital. The grade reflects a fragile balance sheet that requires careful management to avoid a liquidity crisis.
2. Key Vital Signs
| Vital Sign | Value | Interpretation |
|---|---|---|
| Net Assets (Equity) | -£97,870 | Negative equity: liabilities exceed assets. This is a critical sign of financial weakness, akin to a patient with more debt than assets. |
| Current Ratio | 4.28 | Current assets are 4.28 times current liabilities. Looks healthy, but current assets are 94.9% debtors (not cash). Like a strong pulse but weak circulation if receivables are not collected. |
| Cash Ratio | 0.21 | Cash covers only 21% of current liabilities. Low cash reserves – similar to low blood pressure, leaving little buffer for shocks. |
| Debt to Assets | 89.2% | Total liabilities are 89.2% of total assets. High leverage – like high cholesterol, increasing financial risk. |
| Profitability (inferred) | +£128,056 | Net assets improved from -£225,926 to -£97,870, implying a profit. A positive sign – the fever is breaking. |
| Revenue Growth (proxy) | Trade debtors up from £48,524 to £577,761 | Massive increase in trade debtors suggests rapid sales growth, but also collection risk. |
| Employees | 16 (2024: 12) | Growing workforce, indicating expansion. |
3. Diagnosis
ESPANARO LTD is a growing business – trade debtors have surged, employee numbers are up, and the company has returned to profitability in 2025 after a significant loss in 2024. However, this growth has been financed largely by debt, leaving the company with negative equity and a highly leveraged balance sheet. Total liabilities (£705,508) exceed total assets (£790,829) by £97,870, meaning the company is technically insolvent on a balance-sheet basis.
The cash position is tight: only £37,960 cash against £181,395 of current liabilities. The company relies on its large debtor book (£738,148, of which £577,761 is trade debtors) to meet obligations. If these receivables are collected promptly, liquidity is manageable; if not, the company could face a cash crunch.
Other symptoms of distress include: - Overdrawn director’s loan account of £70,013 (a negative creditor, meaning the director owes the company). This is a related-party red flag and may have tax implications. - Unusual negative proposed dividend of £35,476 – this is unclear and should be investigated. - High long-term debt: bank loans £358,096 plus other creditors £347,412. The new “other creditors” of £347,412 is a significant liability that may carry restrictive covenants or high interest.
On the positive side, the company has positive working capital (£594,713) and made a profit in 2025, reducing the accumulated deficit. The business operates in defence and security software – a niche sector with potential for high margins, but also long sales cycles and collection risk.
Overall diagnosis: The company is in a fragile recovery phase. It has the symptoms of financial distress (negative equity, high leverage, low cash) but is not yet in critical condition. The next 12–24 months will be decisive: if growth is managed prudently and receivables are converted to cash, the company can strengthen its balance sheet. If not, it risks insolvency.
4. Recommendations
- Implement strict credit control – Prioritise collection of the £577,761 trade debtors. Consider invoice discounting or factoring to accelerate cash inflow.
- Reduce leverage – Explore refinancing or converting some debt to equity. An equity injection (e.g., from the director or external investors) would immediately improve net assets and reduce reliance on debt.
- Clarify director’s loan and proposed dividend – The overdrawn director’s loan account (£70,013) should be repaid or formally documented. The negative proposed dividend (£35,476) requires correction or explanation.
- Build cash reserves – Aim to hold at least 3 months of operating expenses in cash. Currently, cash covers less than one month of current liabilities.
- Monitor profitability monthly – Maintain the 2025 turnaround by tracking gross margins and overheads. Avoid overtrading – growth must be funded, not just booked as debtors.
- Review debt covenants – Ensure compliance with bank loan terms and assess the impact of the £347,412 “other creditors” on future flexibility.
- Consider a formal restructuring plan – If negative equity persists, a capital restructuring (e.g., debt-for-equity swap) may be necessary to restore balance-sheet health.